Immunization with a Pentameric L1 Fusion Protein Protects against Papillomavirus Infection

The prophylactic papillomavirus vaccines currently in clinical trials are composed of viral L1 capsid protein that is synthesized in eukaryotic expression systems and purified in the form of virus-like particles (VLPs). To evaluate whether VLPs are necessary for effective vaccination, we expressed t...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Yuan, Hang, Estes, Patricia A., Chen, Yan, Newsome, Joseph, Olcese, Vanessa A., Garcea, Robert L., Schlegel, Richard
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology 2001
Témata:
Pathogenesis and Immunity
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC115027/
https://ncbi.nlm.nih.gov/pubmed/11483728
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.75.17.7848-7853.2001
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky